Elizabeth L. Hougen

2016

In 2016, Elizabeth L. Hougen earned a total compensation of $2.1M as Senior Vice President, Finance and Chief Financial Officer at Ionis Pharmaceuticals, a 11% increase compared to previous year.

Compensation breakdown

Bonus$297,244
Option Awards$1,117,834
Salary$412,839
Stock Awards$279,647
Other$25,670
Total$2,133,234

Hougen received $1.1M in option awards, accounting for 52% of the total pay in 2016.

Hougen also received $297.2K in bonus, $412.8K in salary, $279.6K in stock awards and $25.7K in other compensation.

Rankings

In 2016, Elizabeth L. Hougen's compensation ranked 4,591st out of 14,075 executives tracked by ExecPay. In other words, Hougen earned more than 67.4% of executives.

ClassificationRankingPercentile
All
4,591
out of 14,075
67th
Division
Manufacturing
1,629
out of 5,489
70th
Major group
Chemicals And Allied Products
505
out of 1,895
73rd
Industry group
Drugs
373
out of 1,538
76th
Industry
Pharmaceutical Preparations
295
out of 1,176
75th
Source: SEC filing on April 10, 2017.

Hougen's colleagues

We found five more compensation records of executives who worked with Elizabeth L. Hougen at Ionis Pharmaceuticals in 2016.

2016

Stanley Crooke

Ionis Pharmaceuticals

Chief Executive Officer

2016

B Parshall

Ionis Pharmaceuticals

Chief Operating Officer

2016

Brett Monia

Ionis Pharmaceuticals

Senior Vice President,

2016

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

2016

Patrick O'Neil

Ionis Pharmaceuticals

General Counsel

News

In-depth

You may also like